drugset / Trial / NCT06980649
Study of BHV-1300 in Graves' Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves' Disease and to explore its effect on disease-specific biomarkers.
Timeline
- Start
- 2025-08-21
- Primary completion
- 2027-09
- Completion
- 2027-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BHV-1300 | Unknown | — | Subcutaneous |